← Eichor
Condition: Hairy Cell Leukemia Variant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hairy Cell Leukemia Variant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04322383Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
Phase 2 · 21 location(s) · National Cancer Institute (NCI) · NCT06311227Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Varian
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04815356
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.